指南与共识骨质疏松与代谢性骨病

骨质疏松症的目标治疗策略是否适用于临床实践?欧洲专家组的共识

Is a treat-to-target strategy in osteoporosis applicable in clinical practice? Consensus among a panel of European experts.
指南 / 共识 · Osteoporos Int · 2020-08-07

欧洲12名临床专家(来自8个国家)通过改良德尔菲法进行三轮盲法远程电子调查,对13条关于骨质疏松症目标治疗(T2T)策略的陈述进行投票,共识定义为≥75%同意。全部13条陈述均达成共识:T2T策略适用于骨质疏松症,全髋骨密度是目前临床实践中最合适的治疗目标;但具体骨密度目标值和时限未达成明确共识,需个体化确定。

要点

  • 脆性骨折患者最重要的治疗目标是恢复骨折前功能水平和降低再骨折风险。
  • 专家组共识认为T2T策略适用于骨质疏松症,全髋骨密度是目前最合适的治疗目标。
  • 具体骨密度目标值和时限未达成明确共识,需个体化确定。

核心结论

  • 专家组共识认为T2T策略适用于骨质疏松症,全髋骨密度似乎是T2T策略下最临床上合适的治疗目标。
  • 脆性骨折管理的主要目标是恢复骨折前功能水平和降低骨折风险。

研究设计与样本

  • 采用改良德尔菲法,由12名来自8个欧洲国家的临床专家进行三轮盲法远程电子调查投票。
  • 专家对13条关于骨质疏松症T2T策略的最终陈述进行投票,共识定义为≥75%同意。
  • 专家由UCB Pharma遴选,该公司提供财务和后勤支持。

主要发现

  • 13/13条陈述达成共识。
  • 专家组同意脆性骨折患者最重要的目标是恢复骨折前功能水平和降低再骨折风险。
  • 专家组共识认为T2T策略适用于骨质疏松症,骨密度是目前最临床上合适的治疗目标。
  • 关于具体骨密度治疗目标值和T2T适用时限的定义,未达成明确共识,专家强调需个体化确定。

关键数值与推荐

  • 共识定义为≥75%同意某条陈述。
  • 投票采用Likert量表:强烈不同意、不同意、无法回答、同意、强烈同意。
  • 13条最终陈述均达成共识(13/13)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: A panel of European experts was convened to establish consensus on a treat-to-target strategy in osteoporosis. Panellists agreed that the ultimate goals of treating osteoporosis are recovering pre-fracture functional level and reducing subsequent fracture risk; there was consensus that total hip bone mineral density is currently the most appropriate treatment target in clinical practice. INTRODUCTION: A modified Delphi approach was convened to establish consensus among European experts on best practice management for patients with fragility fractures and whether a treat-to-target (T2T) strategy is applicable in osteoporosis. METHODS: A panel of 12 clinical experts (from eight European countries) voted on 13 final statements relating to a T2T strategy for osteoporosis across three rounds of blinded, remotely conducted electronic surveys (Likert scale: 'strongly disagree', 'disagree', 'unable to answer', 'agree', 'strongly agree'). When panellists disagreed, they were asked how the statement could be adjusted to allow for a positive response, which was used to refine the statement for the following round. Consensus was defined as ≥ 75% agreement with a statement. Panellists were selected by UCB Pharma, which provided financial and logistical support. RESULTS: Consensus was reached for 13/13 statements. Panellists agreed that the most important goals for fragility fracture patients are recovery of pre-fracture functional level and reduction of subsequent fracture risk. There was also consensus that a T2T strategy is applicable to osteoporosis and that bone mineral density (BMD) is currently the most clinically appropriate target. With regard to the definition of a specific BMD treatment target and timeframes applicable to T2T in osteoporosis, no clear consensus was reached; panellists emphasised that these would need to be individually determined. CONCLUSIONS: According to a panel of European experts, the main goals of fracture management are to recover pre-fracture functional level and reduce fracture risk. Total hip BMD seems to be the most clinically appropriate treatment target within a T2T strategy.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Thomas T, Casado E, Geusens P, et al. Is a treat-to-target strategy in osteoporosis applicable in clinical practice? Consensus among a panel of European experts. Osteoporos Int. 2020. PMID: 32767094. doi:10.1007/s00198-020-05569-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。